StonvexLoading…
StonvexCore line items from SRAD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | €1.29B | €1.11B | €877.62M | €730.19M |
Operating Income | €118.76M | €22.55M | €47.20M | €17.79M |
Net Income | €100.32M | €33.61M | €33.89M | €10.49M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | €2.87B | €2.29B | €2.25B | €1.39B |
Total Liabilities | €1.89B | €1.36B | €1.37B | €631.63M |
Cash & Equivalents | €365.30M | €348.36M | €277.17M | €243.76M |
Free Cash Flow OCF − CapEx | €398.11M | €347.64M | €243.86M | €159.79M |
Shares Outstanding | Not available | Not available | Not available | Not available |